missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. SARS-CoV-2 Spike RBD LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™

SARS-CoV-2 Spike RBD LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™
GREENER_CHOICE

Llama Monoclonal Antibody

178.00 € - 468.00 €

Specifications

Antigen Spike RBD
Clone L009.2.69H
Dilution Blockade of Receptor-ligand Interaction
Applications Blocking Assay
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18782377
GREENER_CHOICE
View Documents
missing translation for 'viewProductCertificates'
R&D Systems
LMAB10870-SP 		25 μg
178.00 €
25µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
18772607
GREENER_CHOICE
View Documents
missing translation for 'viewProductCertificates'
R&D Systems
LMAB10870-100 		100 μg
468.00 €
100µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Spike RBD Monoclonal antibody specifically detects Spike RBD in SARS-CoV-2 samples. It is validated for Blocking Assay
Specifications

Specifications

Spike RBD
Blockade of Receptor-ligand Interaction
Monoclonal
Purified
RUO
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Protein A or G purified from cell culture supernatant
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
L009.2.69H
Blocking Assay
Unconjugated
Llama
SARS-CoV-2
YP_009724390.1
Primary
Reconstitute at 0.5 mg/mL in sterile PBS.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.